InterChem is a Ukrainian pharmaceutical manufacturer with strong R&D (est. 1992). The company makes 50+ branded medicines and 10+ APIs at GMP-certified facilities. Innovative in-house products generate nearly 60% of sales, underlining InterChem's leadership in the region. Strategic focus: discovery, development and market support of novel molecules. The research cluster Bureau of Medicines' Molecules Design & Development (BM2D2) drives at least three CNS projects, opening new opportunities to expand their future market impact together with trusted partners.